• Home
  • Texas Christian University
  • Advanced Pharmacology NRAN 60134
  • Advanced Pharmacology NRAN 60134

Advanced Pharmacology NRAN 60134

Uastificafions -Classifications are broad sWocategories, for drugs 6roWping drugs by +neir +nerabeutiG Wse is m0st helpful to the heath care prot esional JOY+3b4 y7dmeu0 aJpo smoM Jn0Y!W!5 U! mpaq 3U+ M2tV m0U+ s0MJd- Tney Wn fit wnder ceNeral casLifiCatioNs lf the hawe 6eNRral therapeutiC effeGs ex:Aspirin...4 classifictions given t reliene pain(anagesic) yprOttupe: a mode examplej a drug -to reduce fener(antipyretic) that typifies th& cnaracteristics Of - to redw& tisue intiammation(anti-intlammatory) a specific dassification. - as an anti-platelet(anti-thrombotiL agent) Top lO DruO aaSificatiOns & EXample CLASSIFICATION I lipia-lowering agents THERAPEUTIC USE DRUG EXAMPLE(S) lowers low density lipoprotein Simvast atin, atorvastatin, (lDL) cnol&sterol rocwastatin lmproves symproms 0f depresslon.AlSo w,ea esuitalopram, sertralinej for anXiety u otner newrologicu aisoraers paroxetine veniafaxine Relieve eenere Pain hydrowaone w| ateiaminophen 0xywdone,oYy morph one tentanyl lowers Heart Rahe & Blooa pressWre metopro(ol,ateno(ol, Pro pranolo) l0wers Blooa preSwre Lisinopril,enalapriL valsartan inarease wrinary output fwrosemide ReaWces Blood 6lWo e(sugar) leNels insulingmetformin g lipizid&Janwia Eliminates intection amoxiallin, wpna exin, doxywycline DeUreaseS stomaUn ACidity Omeprazoie Panto prarole esomeprawle Decreases dotting in Blood 2.nnti-depresants 3.NarwtiC Andugesics 4 BeKa BIOUKerS S.Antinypertensives Y!fJM!0 0 l. AntidiabetcS 8. AntibiotiCs 9. proton pump Inhibitors (0. AnitoagWants Identifying name. Fowr Specifie Names can apply to eacn apPhoved druq t. Generic Name aCommon or generaU name aigned h the drug by the US Adopted Name (VSAN)cownCl) b.Differentiated from trade name by initia lowercase letter c.Never capitalired (hiro dWor Rq p?umo 2W^DM pvnou9 u0 hmfo!Udayd vm] 2W^0N opeuI Z 3 Name by wnicn pharmaCelfia wmpany identifies its produCt b.wopyrightld& Wbta exCiusively by that Wmpany c- Distingwished from generic namt by capitalized Ist (etter d.0ftn shOwn on lWoes & references wI Hhe sYmbo\ @ after Hhe name(for "registered" trademark) 3.cnemical Name a.exak moleWWr formua ot the drug b.vsually a long,very difficult name to pronownce c of little concern to the hlalth care professional 4 0ffiCial Name a.Name Of drug as it appears in the ofticia reference the vs PharmaWpea|Nahional formwlaru (vsp/Nf b benerally the same as the generic name For 5 yearsfrom the tiMe the wmpany sWbmiHs a neW drug appliCation(NDA) t the FDA for approVau,tne WoMpany ha the exdUgive right to market thi drug.on&e the patent has txpired,Other Wompanies may begin to Create the same generic product & eacn wmpany will give Hs own trade name. to sUO!s!nud 2Itn2as 3bnm 7w^0N pumj9 p3q!NS2ud jay StVnmAmb 7jraVo6 2N!gVoax2 SS2) 2m+HSms drug substifution laws vary sfate to State. The physician may indicare "no swbktwkons" wsually written as a dispence as writtenloAw) oraer they often haNe preferenwS for certain products or pahients may be ditfiWt to siabili& on a wrtain cass ot mediations lt can Vary noW auuCKly a drug dicsolveS or taKs etfect. Dyes in 6ome phoduCts may iead h auIergic response in some patients. patient Education The FDA regulates the manuraltwring ot generic arugs,so patiens can be ascured thar they are sate & wt-efective auternatives. Trade namo products are usually more expensivemoctly due to the costs ot marketing & adwertising. Some traal nane produts nave #jueuauy to indiwe a dutterent strengt